Table 1 Demographic and baseline characteristics of the two patient groups (N = 615)
Characteristics | All | Low ALI | High ALI | P value |
|---|---|---|---|---|
(N = 615) | (N = 253) | (N = 362) | ||
Gender | 0.434 | |||
Female | 146(23.7) | 56(22.1) | 90(24.9) | |
Age ≥ 65 years | 201(32.7) | 93(36.8) | 108(29.8) | 0.072 |
ALI | 44.71(29.98–60.65) | 27.09(20.39–32.76) | 57.19(48.64–73.58) | < 0.001 |
BMI, kg/m2 | 22.04(20–24.56) | 21.01(19.03–23.08) | 22.81(20.83–25.23) | < 0.001 |
Albumin, g/l | 38.76 ± 4.51 | 37.06 ± 4.84 | 39.95 ± 3.84 | < 0.001 |
NLR | 1.95(1.45–2.72) | 2.88(2.36–3.78) | 1.56(1.23–1.88) | < 0.001 |
T stage | < 0.001 | |||
T1 | 148(24.1) | 44(17.4) | 104(28.7) | |
T2 | 46(7.5) | 11(4.3) | 35(9.7) | |
T3 | 60(9.8) | 28(11.1) | 32(8.8) | |
T4 | 361(58.7) | 170(67.2) | 191(52.8) | |
N stage | 0.043 | |||
N0 | 280(45.5) | 108(42.7) | 172(47.5) | |
N1 | 87(14.1) | 28(11.1) | 59(16.3) | |
N2 | 111(18) | 49(19.4) | 62(17.1) | |
N3 | 137(22.3) | 68(26.9) | 69(19.1) | |
TNM stage | < 0.001 | |||
I | 170(27.6) | 48(19) | 122(33.7) | |
II | 74(12) | 28(11.1) | 46(12.7) | |
III | 371(60.3) | 177(70) | 194(53.6) | |
Chemotherapya | 0.152 | |||
yes | 378(61.5) | 164(64.8) | 214(59.1) | |
no | 237(38.5) | 89(35.2) | 148(40.9) | |
Histology | 0.341 | |||
differentiated | 193(31.4) | 74(29.2) | 119(32.9) | |
undifferentiated | 422(68.6) | 179(70.8) | 243(67.1) | |
Tumor location | 0.135 | |||
proximal stomach | 161(26.2) | 75(29.6) | 86(23.8) | |
distal stomach | 357(58) | 135(53.4) | 222(61.3) | |
total stomach | 97(15.8) | 43(17) | 54(14.9) | |
OS, month | 40(27–64) | 37(16.5–57.5) | 42(32–65) | < 0.001 |
DFS, month | 40(25–63) | 37(15–56) | 42(31–65) | < 0.001 |
LPR | 0.05(0–0.29) | 0.09(0–0.34) | 0.04(0–0.27) | 0.051 |
Tumor size, cm | 4(2.5–5.5) | 5(3–6.5) | 3.5(2.1–5) | < 0.001 |